NSAID Exacerbated Respiratory Disease (N-ERD) is characterized by nasal polyp formation, asthma, and hypersensitivity to all cyclooxygenase-1 (COX-1) inhibitors, which are commonly used non-steroidal anti-inflammatory drugs (NSAIDs). The gene discussed is PTGS1; the disease is Nasal polyposis.